Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 97

Sort by

Sort Order Select

Journal Articles

Identification of a development-restricted, megakaryocyte-primed population of hematopoietic progenitor cells during fetal and early postnatal development

Ryan Mack, Rohit Thalla, Lei Zhang, Kanak Joshi, Wei Wei, Peter Breslin, Jiwang Zhang

Blood (2025) 146 (Supplement 1): 4936.

https://doi.org/10.1182/blood-2025-4936

Published: 2025

Journal Articles

CD27, CD62L and ESAM define a multipotent progenitor population with megakaryocytic potential

Ryan Mack, Rohit Thalla, Lei Zhang, Kanak Joshi, Peter Breslin, Wei Wei, Jiwang Zhang

Blood (2025) 146 (Supplement 1): 4935.

https://doi.org/10.1182/blood-2025-4935

Published: 2025

Journal Articles

Black lives advocating for clot knowledge (B.L.A.C.K) national blood clot alliance church bus tour: A community-based blood clot education and awareness campaign

Dana Angelini, Rushad Patell, Wei Wei, Anna Parks, Jori May, Alejandra Gutierrez Bernal, Jordan Schaefer, Shruti Chaturvedi, Anjlee Mahajan, Ang Li, Leben Tefera, Tarin Patrikis, Teresa Bordeaux, Phalan Bolden, Gretchen Piller, Karen Adams, Leslie Lake, Caroline Cromwell

Blood (2025) 146 (Supplement 1): 829.

https://doi.org/10.1182/blood-2025-829

Published: 2025

Journal Articles

Prognostic factors and survival outcomes of urgent inpatient chemotherapy for relapsed/refractory lymphoma in the modern era

Abhishek Kataria, Mikhaila Rice, Wei Wei, Faiz Anwer, Paolo Caimi, Allison Winter, Robert Dean, Taylor Brooks, Joslyn Rudoni, Jack Khouri, Christy Samaras, Shahzad Raza, Sandra Mazzoni, Jason Valent, Brian Hill, Deepa Jagadeesh

Blood (2025) 146 (Supplement 1): 2737.

https://doi.org/10.1182/blood-2025-2737

Published: 2025

Journal Articles

Outcomes of urgent inpatient chemotherapy for relapsed/refractory multiple myeloma in the modern era

Blood (2025) 146 (Supplement 1): 4601.

https://doi.org/10.1182/blood-2025-4601

Published: 2025

Journal Articles

Melphalan weight-based dosing in overweight and obese patients undergoing autologous transplant for multiple myeloma

Anmol Goyal, Daniel Cancilla, Wei Wei, Danielle Cenin, Faiz Anwer, Claudio Brunstein, Shahzad Raza, Louis Williams, Jack Khouri

Blood (2025) 146 (Supplement 1): 4033.

https://doi.org/10.1182/blood-2025-4033

Published: 2025

Journal Articles

Final results of a phase I/II trial of palbociclib and CPX-351 in patients with Acute Myeloid Leukemia

Chana Peysin, Aziz Nazha, Wei Wei, Aaron Gerds, Xiaoying Chen, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Eric Parsons, Jenna Thomas, Bhumika Patel, Jaroslaw Maciejewski, Mikkael Sekeres, Babal Jha, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3420.

https://doi.org/10.1182/blood-2025-3420

Published: 2025

Journal Articles

Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium

Blood (2025) 146 (Supplement 1): 904.

https://doi.org/10.1182/blood-2025-904

Published: 2025

Journal Articles

Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database

Jan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, Wei Wei, Najla Al Ali, Amy DeZern, Mikkael Sekeres, Geoffrey Uy, Samuel Urrutia, Hetty Carraway, Pinkal Desai, Elizabeth Griffiths, Eytan Stein, Andrew Brunner, Christine McMahon, Rory Shallis, Joshua Zeidner, Michael Savona, Hayley Hawkins, Namrata Chandhok, Constantine Logothetis, Aram Bidikian, Theodore Getz, Gail Roboz, Benjamin Rolles, Eunice Wang, Amyah Harris, Maria Amaya, Somedeb Ball, Justin Grenet, Zhuoer Xie, Yazan Madanat, Yasmin Abaza, Jaclynn Campos, Talha Badar, Torsten Haferlach, Jaroslaw Maciejewski, David Sallman, Anoop Enjeti, Kamal Alrabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vassiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Max Stahl, Matteo Della Porta, Rami Komrokji, Amer Zeidan

Blood (2025) 146 (Supplement 1): 606.

https://doi.org/10.1182/blood-2025-606

Published: 2025

Journal Articles

Outcomes in Patients with Cancer-Associated Venous Thromboembolism Receiving Immune Checkpoint Inhibitors: A Matched Cohort Study

Pedro Luiz Lage Bodour Danielian, Heloni M. Dave, Wei Wei, Mehrie H Patel, Dana Elizabeth Angelini, Alok A. Khorana

Blood (2024) 144 (Supplement 1): 5578.

https://doi.org/10.1182/blood-2024-211304

Published: 2024

Journal Articles

Clinical Outcomes and Variability Based on Baseline Cytogenetic Risk of Patients with MDS Treated with Hypomethylating Agents: An Analysis from the International Consortium for MDS (icMDS) Validate Database

Ted M. Getz, Tariq Kewan, Jan Philipp Bewersdorf, Jessica M. Stempel, Luca Lanino, Wei Wei, Najla H. Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L. Uy, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Christine M. McMahon, Rory M. Shallis, Joshua F Zeidner, Michael R. Savona, Somedeb Ball, Namrata S. Chandhok, Constantine Logothetis, Aram Bidikian, Gail J. Roboz, Benjamin Rolles, Eunice S. Wang, Amyah C. Harris, Maria L Amaya, Hayley Hawkins, Justin Grenet, Zhuoer Xie, Yazan F. Madanat, Yasmin Abaza, Talha Badar, Torsten Haferlach, Jaroslaw Maciejewski, David Sallman, Anoop K Enjeti, Kamal Al-Rabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vasiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Maximilian Stahl, Matteo Giovanni Della Porta, Rami S. Komrokji, Amer M. Zeidan

Blood (2024) 144 (Supplement 1): 3219.

https://doi.org/10.1182/blood-2024-202075

Published: 2024

Journal Articles

Assessment of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplant When Comparing Treatment with and without Post-Transplant Cyclophosphamide

Daniel P. Nurse, Wei Wei, Amanda Burns, Joseph Farinella, Deepa Jagadeesh, Robert M. Dean, Rabi Hanna, Seth J Rotz, Aaron T. Gerds, Claudio Brunstein, Matt Kalaycio, Craig S. Sauter, Betty K. Hamilton, Ronald Sobecks

Blood (2024) 144 (Supplement 1): 7383.

https://doi.org/10.1182/blood-2024-202626

Published: 2024

Journal Articles

Uncovering the HOXA9 Translational Regulatory Complex That Promotes AML Leukemic Stem Cells

Xueqin Xie, Florisela Herrejon Chavez, Ilyes Baali, Eren L. Chu, Chiara Evans, Xuejing Yang, Wei Wei, Hanzhi Luo, Sun Mi Park, Kathryn Chang, Aspen Pierson, Grace Han, Emily Batchelor, Quaid D. Morris, Ly Vu, Diu T.T. Nguyen, Michael G. Kharas

Blood (2024) 144 (Supplement 1): 4106.

https://doi.org/10.1182/blood-2024-211477

Published: 2024

Journal Articles

Analysis of Factors Influencing Enrollment Success in Hematology Malignancy Cancer Clinical Trials (2008-2023)

Rupayan Kundu, Xiaoying Chen, Wei Wei, Debolina Pramanik, Yash Agarwal, Arjun Chatterjee, Akriti G. Jain, Abhay Singh, Aaron T. Gerds, Hetty E. Carraway, Moaath K. Mustafa Ali, John C. Molina, Sophia Balderman, Sudipto Mukherjee

Blood (2024) 144 (Supplement 1): 5059.

https://doi.org/10.1182/blood-2024-207446

Published: 2024

Journal Articles

Genetic Profiling and Survival Analysis of Patients with Acute Myeloid Leukemia and a History of Autoimmune Disease

Blood (2024) 144 (Supplement 1): 6127.

https://doi.org/10.1182/blood-2024-199358

Published: 2024

Journal Articles

A Multicenter Real-World Analysis (RWA) of Primary Cutaneous Anaplastic Large Cell Lymphoma (PCALCL) Treated in the Modern Era

Deepa Jagadeesh, Stefan K. Barta, Jonathan E. Brammer, Wei Wei, Julie E Chang, Rahul Mishra, Tavakkoli Montreh, Alma Habib, Marcus P Watkins, Yash Deshmukh, Sharina C Macapagal, Madiha Iqbal, N. Nora Bennani, Frederick Lansigan, Neha Mehta-Shah

Blood (2023) 142 (Supplement 1): 6177.

https://doi.org/10.1182/blood-2023-191176

Published: 2023

Journal Articles

Safety Results of a Phase I Study of Zandelisib + R-CHOP in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL)

Deepa Jagadeesh, Paolo Caimi, Allison Winter, Wei Wei, Brad Pohlman, Christopher D'Andrea, Emily Rhoades, Robert M. Dean, Brian T. Hill

Blood (2023) 142 (Supplement 1): 6233.

https://doi.org/10.1182/blood-2023-191345

Published: 2023

Journal Articles

Resource Utilization Analysis of Two Algorithms for Hematopoietic Progenitor Cell Mobilization in Multiple Myeloma

Daniel Cancilla, Daniel (Paul) Nurse, Wei Wei, Christina Ferraro, Brian Matia, Julie Coffman, Craig S Sauter, Betty K. Hamilton, Jack Khouri

Blood (2023) 142 (Supplement 1): 6942.

https://doi.org/10.1182/blood-2023-178831

Published: 2023

Journal Articles

A Retrospective Study of Patient Characteristics, Treatment Patterns and Outcomes in Patients with Primary CNS Lymphoma

Thomas Curley, Wei Wei, Christine Cordova, David Peereboom, Mina Lobbous, Allison Winter

Blood (2023) 142 (Supplement 1): 4492.

https://doi.org/10.1182/blood-2023-190843

Published: 2023

Journal Articles

Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma

Zhihui Song, Wenjun Wu, Wei Wei, Wenming Xiao, Michelle Lei, Kathy Q. Cai, Da Wei Huang, Subin Jeong, Jing-Ping Zhang, Hongbo Wang, Marshall E. Kadin, Thomas A. Waldmann, Louis M. Staudt, Masao Nakagawa, Yibin Yang

Blood (2023) 142 (15): 1297–1311.

https://doi.org/10.1182/blood.2022019166

Published: 2023

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Identification of a development-restricted, megakaryocyte-primed population of hematopoietic progenitor cells during fetal and early postnatal development

CD27, CD62L and ESAM define a multipotent progenitor population with megakaryocytic potential

Black lives advocating for clot knowledge (B.L.A.C.K) national blood clot alliance church bus tour: A community-based blood clot education and awareness campaign

Prognostic factors and survival outcomes of urgent inpatient chemotherapy for relapsed/refractory lymphoma in the modern era

Outcomes of urgent inpatient chemotherapy for relapsed/refractory multiple myeloma in the modern era

Melphalan weight-based dosing in overweight and obese patients undergoing autologous transplant for multiple myeloma

Final results of a phase I/II trial of palbociclib and CPX-351 in patients with Acute Myeloid Leukemia

Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium

Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database

Outcomes in Patients with Cancer-Associated Venous Thromboembolism Receiving Immune Checkpoint Inhibitors: A Matched Cohort Study

Clinical Outcomes and Variability Based on Baseline Cytogenetic Risk of Patients with MDS Treated with Hypomethylating Agents: An Analysis from the International Consortium for MDS (icMDS) Validate Database

Assessment of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplant When Comparing Treatment with and without Post-Transplant Cyclophosphamide

Uncovering the HOXA9 Translational Regulatory Complex That Promotes AML Leukemic Stem Cells

Analysis of Factors Influencing Enrollment Success in Hematology Malignancy Cancer Clinical Trials (2008-2023)

Genetic Profiling and Survival Analysis of Patients with Acute Myeloid Leukemia and a History of Autoimmune Disease

A Multicenter Real-World Analysis (RWA) of Primary Cutaneous Anaplastic Large Cell Lymphoma (PCALCL) Treated in the Modern Era

Safety Results of a Phase I Study of Zandelisib + R-CHOP in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL)

Resource Utilization Analysis of Two Algorithms for Hematopoietic Progenitor Cell Mobilization in Multiple Myeloma

A Retrospective Study of Patient Characteristics, Treatment Patterns and Outcomes in Patients with Primary CNS Lymphoma

Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only